Summary
Diazyme Laboratories Inc (Diazyme Laboratories) is a diagnostic reagents developer. The company offers test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. It offers products by markers, instrument specific packaging, point of care, DZ lite instrument, analyzer parameters, data sheets. Diazyme Laboratories offers anemia markers, cancer markers, cardiovascular markers, coagulation markers, diabetic markers, electrolyte markers, inflammatory markers, liver markers, renal and pancreatic marker, sepsis marker and vitamin marker. The company’s technology comprise enzyme cycling technology, latex enhanced immunoassay and enzyme-immunoassay. Diazyme Laboratories is headquartered in Poway, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diazyme Laboratories Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
- Diazyme Laboratories Inc Company Overview
- Diazyme Laboratories Inc Company Snapshot
- Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
- Diazyme Laboratories Inc – Pipeline Analysis Overview
- Diazyme Laboratories Inc - Key Facts
- Diazyme Laboratories Inc - Major Products and Services
- Diazyme Laboratories Inc Pipeline Products by Development Stage
- Diazyme Laboratories Inc Pipeline Products Overview
- B7-H4 Assay
- B7-H4 Assay Product Overview
- DcR3 (DD-C248) Assay
- DcR3 (DD-C248) Assay Product Overview
- MIC-1 (DD-X065) Assay
- MIC-1 (DD-X065) Assay Product Overview
- ProADM Point-of-Care
- ProADM Point-of-Care Product Overview
- ProADM Test
- ProADM Test Product Overview
- ProANP Test
- ProANP Test Product Overview
- ProET1 Test
- ProET1 Test Product Overview
- Spondin-2 (DD-P108) Assay
- Spondin-2 (DD-P108) Assay Product Overview
- TRAIL-R2 Assay
- TRAIL-R2 Assay Product Overview
- Diazyme Laboratories Inc - Key Competitors
- Diazyme Laboratories Inc - Key Employees
- Diazyme Laboratories Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Diazyme Laboratories Inc, Recent Developments
- Jul 16, 2018: Ortho Clinical Diagnostics Launches New MicroTip Partnership Assays for Diabetes, Cardiac and Renal Testing, In Collaboration with Diazyme Laboratories
- Jan 25, 2018: Stryker’s DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association
- Jan 22, 2018: FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers
- Jun 21, 2017: Beckman Coulter Diagnostics Expands Chemistry Menu to Include FDA-cleared Procalcitonin
- Nov 28, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Direct HbA1c (Enzymatic, On-Board Lysis) Assay for Clinical Chemistry Analyzers
- Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Folate Assay for Clinical Chemistry Analyzers
- Nov 21, 2016: FDA Grants Diazyme 510(k) Clearance to Market Its Vitamin B12 Assay for Clinical Chemistry Analyzers
- Jul 22, 2016: Get Reliable Results with the Diazyme 25-OH Vitamin D Assay for Clinical Chemistry Analyzers
- May 23, 2016: Diadexus and Sonic Healthcare USA Sign National Agreement for PLAC Activity Test
- Nov 10, 2015: Diadexus Presents New PLAC Activity Data From the REGARDS Study at 2015 American Heart Association Scientific Sessions
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Diazyme Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview
- Diazyme Laboratories Inc Pipeline Products by Equipment Type
- Diazyme Laboratories Inc Pipeline Products by Indication
- Diazyme Laboratories Inc, Key Facts
- Diazyme Laboratories Inc, Major Products and Services
- Diazyme Laboratories Inc Number of Pipeline Products by Development Stage
- Diazyme Laboratories Inc Pipeline Products Summary by Development Stage
- B7-H4 Assay - Product Status
- B7-H4 Assay - Product Description
- DcR3 (DD-C248) Assay - Product Status
- DcR3 (DD-C248) Assay - Product Description
- MIC-1 (DD-X065) Assay - Product Status
- MIC-1 (DD-X065) Assay - Product Description
- ProADM Point-of-Care - Product Status
- ProADM Point-of-Care - Product Description
- ProADM Test - Product Status
- ProADM Test - Product Description
- ProANP Test - Product Status
- ProANP Test - Product Description
- ProET1 Test - Product Status
- ProET1 Test - Product Description
- Spondin-2 (DD-P108) Assay - Product Status
- Spondin-2 (DD-P108) Assay - Product Description
- TRAIL-R2 Assay - Product Status
- TRAIL-R2 Assay - Product Description
- Diazyme Laboratories Inc, Key Employees
- Diazyme Laboratories Inc, Subsidiaries
- Glossary
- List of Figures
- Diazyme Laboratories Inc Pipeline Products by Equipment Type
- Diazyme Laboratories Inc Pipeline Products by Development Stage